Tag Archives: Pharmacy (TRBC level 3)

Bharat Biotech offers a potential Brazilian COVID-19 vaccine | Instant News

FILE PHOTO: A man rides his motorbike past a bus parked by Indian biotech firm Bharat Biotech outside its offices in Hyderabad, India, July 3, 2020. REUTERS / Stringer / File Photo

BRASILIA (Reuters) – Bharat Biotech India this week offered a COVID-19 vaccine to Brazil that is in its final stage of clinical trials and a possible technology transfer partnership, a company executive said on Friday.

A private pharmaceutical company based in the southern city of Hyderabad is developing a whole virion inactivated vaccine called Covaxin that could be licensed in the second quarter of 2021.

“The data looks very good in terms of both reduction and prevention of disease, and we are starting Phase 3 clinical trials this week,” Executive Director Sai Prasad told Reuters.

Bharat Biotech is currently recruiting 26,000 volunteers in India for trials and results are expected between March and April, he said.

Pfizer Inc said on Wednesday that it had offered to provide Brazil with millions of doses of the COVID-19 vaccine in the first half of 2021, amid evidence that the coronavirus is spreading faster in South America’s largest country.

Pfizer and German partner BioNTech SE report the results of recent trials showing the vaccine is 95% effective in preventing COVID-19.

Bharat Biotech representatives met this week with Brazil’s health ministry and regulatory agency officials to see what are the requirements for vaccine licensing in Brazil and whether trials should take place there as well.

“We are very open to partnerships and technology transfer,” Prasad said in an interview from Hyderabad.

Bharat Biotech has sold a Hepatitis B vaccine to Brazil and is developing another vaccine for Zika and Chicungunya that the South American country is interested in, he said.

Reporting by Anthony Boadle; Edited by Nick Macfie


image source

Britain hopes that Christmas can be saved as COVID cases become more prevalent | Instant News

LONDON (Reuters) – Britain could relax strict COVID-19 rules to allow families to gather for Christmas as signs show that coronavirus cases are starting to level off due to the current lockdown, Health Minister Matt Hancock said on Friday.

Britain has the worst official number of COVID-19 deaths in Europe and Prime Minister Boris Johnson has imposed some of the strictest restrictions in peacetime history in an effort to stop the spread of the coronavirus.

But ahead of the holiday season, the government faces a dilemma – to loosen restrictions, risk spreading disease and death, or ban large gatherings.

“This of course will not be like an ordinary Christmas, there must be rules in place,” Hancock told Sky News.

He hopes that the restrictions, which include a tight lockdown in Britain, can be relaxed to “allow for more of the normal Christmas that people are really looking forward to”.

Hancock said he is working with delegated governments in Scotland, Wales and Northern Ireland – which are managing their own policies on fighting the pandemic – for a UK-wide approach to the rules for Christmas.

Welsh First Minister Mark Drakeford told BBC TV there will be a meeting next week to discuss the details, and he hopes people in Wales will be able to see relatives and friends in England “in the simplest and most direct way we can plan together”.

London Metropolitan Police Chief, Cressida Dick, said that while police may try to stop wild parties, there is a better use of police time than trying to arrest a family.

“Let’s see what the rules are, but I’m not interested in disrupting the family’s Christmas dinner,” he told LBC radio.

Britain has been in isolation for two weeks, which Hancock says is helping flatten the number of cases. It will end on December 2, although ministers have not ruled out that it could be extended.

Scotland’s largest city, Glasgow, and parts of the country’s western and central regions began a tougher lockdown regime on Friday that lasts until December 11, including the closure of pubs and restaurants and non-essential shops.

Christmas in England usually features a bustling round of office parties, as well as family gatherings that often require long commutes.

Cambridge statistician David Spigelhalter said rules regarding ventilation, speech distance and volume, as well as natural awareness of people, could help during festive periods.

“I was wondering if they would ban singing and maybe they would try to make a rule against family fights at Christmas,” he told BBC radio.

The death toll from the pandemic in Britain stands at 53,775, while the number of tests positive has tested positive for 1,453,256.

Reporting by Alistair Smout, Sarah Young, Kate Holton and Michael Holden, editing by Guy Faulconbridge and Angus MacSwan


image source

Brazil will not relieve the makers of the COVID-19 vaccine from responsibility, said the deputy minister | Instant News

FILE PHOTOS: A vial labeled “Vaccine COVID-19” and a medical syringe seen in an illustration taken April 10, 2020. REUTERS / Dado Ruvic

BRASILIA (Reuters) – Brazil has no intention of enacting a law that would exempt COVID-19 vaccine makers from liability, the country’s deputy health minister Elcio Franco said Thursday.

Franco said a meeting held this week in Brasilia with vaccine developers should lead to a non-binding memorandum of understanding on possible future purchases of a vaccine against COVID-19.

He said the price and target population would be factors in deciding a purchase.

Reporting by Anthony Boadle; Edited by Chris Reese


image source

Switzerland does not expect a liquidity gridlock any time soon – finance minister | Instant News

ZURICH, November 18 (Reuters) – Switzerland does not expect a liquidity crash in the near future to hit businesses in the country, Finance Minister Ueli Maurer said on Wednesday, when the government decided not to reactivate the emergency loan guarantee scheme.

“We don’t need any new state intervention at this time to provide liquidity to the economy,” said Maurer. (Reporting by Brenna Hughes Neghaiwi, editing by John Revill)


image source

Brazil will buy the Pfizer vaccine after the trial is complete, registration with health authorities | Instant News

FILE PHOTO: A bottle with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe visible in front of the Pfizer logo featured in an illustration taken on 31 October 2020. REUTERS / Dado Ruvic / Illustration

BRASILIA (Reuters) – Brazil’s Ministry of Health said in a statement on Tuesday that the country would purchase the Pfizer COVID-19 vaccine once it has been proven safe in clinical trials and registered with domestic health regulators.

The remarks followed a meeting between Brazilian health officials and Pfizer. The pharmaceutical company said last week that the vaccine developed in partnership with BioNTech was more than 90% effective, citing preliminary data.

Reporting by Ricardo Brito, written by Jake Spring, Editing by Rosalba O’Brien


image source